Find a Clinical Trial

Filter By:

Title	Investigator
2-[¹⁸F]-Deoxy-D-Glucose (FDG) and [¹⁸F] Dihydro-Testosterone PET Imaging in Patients with Progressive Prostate Cancer [Protocol 00-095]	Morris, Michael, MD
A Phase I Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer [Protocol 09-035]	Cox, Brett, MD
A Phase I Study of Vaccine Replicon Particles (VRP) Expressing Prostate-Specific Membrane Antigen (PSMA) in Patients with Prostate Cancer [Protocol 08-028]	Slovin, Susan, MD, PhD
A Phase I/II Study of HE3235 in Patients with Prostate Cancer [Protocol 08-090]	Morris, Michael, MD
A Phase I/II Trial of IMC-A12 plus Temsirolimus in Metastatic Castration-Resistant Prostate Cancer [Protocol 09-117]	Rathkopf, Dana, MD, PhD
A Phase II Study of Focal Cryoablation in Low-Risk Prostate Cancer [Protocol 08-118]	Eastham, James, MD
A Phase II Study of Short-Course Androgen Deprivation (Hormonal) Therapy with or without Bevacizumab for PSA Recurrence of Prostate Cancer after Definitive Local Therapy [Protocol 09-123]	Slovin, Susan, MD, PhD
A Phase II Trial of Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer [Protocol 09-008]	Morris, Michael, MD
A Phase III Study of Abiraterone Acetate Plus Prednisone in Men with Metastatic Castration-Resistant Prostate Cancer [Protocol 09-032]	Rathkopf, Dana, MD, PhD
A Phase III Study of Androgen Deprivation with Leuprolide with or without Docetaxel for Clinically Asymptomatic Prostate Cancer Patients with a Rising PSA Following Surgery [Protocol 07-101]	Morris, Michael, MD
A Phase III Study of Docetaxel with and without Dasatinib in Castration-Resistant Prostate Cancer [Protocol 09-050]	Morris, Michael, MD
A Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Bone Problems in Men with Prostate Cancer that Has Spread to the Bone [Protocol 06-091]	Morris, Michael, MD
A Phase III Study of MDV3100 in Patients with Progressive Castration-Resistant Prostate Cancer Previously Treated with Docetaxel-Based Chemotherapy [Protocol 09-085]	Scher, Howard, MD
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer [Protocol 07-041]	Eastham, James, MD
A Phase III Trial of Ipilimumab or Placebo Following Radiotherapy in Patients with Castration-Resistant Prostate Cancer Who Had Prior Treatment with Docetaxel [Protocol 09-126]	Slovin, Susan, MD, PhD
A Phase III Trial of Short-Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed-Only Radiotherapy in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy [Protocol 09-102]	Zelefsky, Michael, MD
A Phase Ib Study of MDX-1106 in Patients with Selected Advanced or Recurrent Malignancies [Protocol 09-012]	Carvajal, Richard, MD
A Pilot Study of High Dose-Rate Prostate Brachytherapy as Salvage Therapy for Locally Recurrent Prostate Cancer Previously Treated with External Beam Radiotherapy [Protocol 06-122]	Yamada, Yoshiya, MD
A Pilot Study of High-Dose Rate Brachytherapy as Definitive Management for Intermediate Risk Prostate Cancer [Protocol 07-120]	Yamada, Yoshiya, MD
A Randomized Trial of Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy [Protocol 09-005]	Mulhall, John, MD
A Study of Avanafil for the Treatment of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy [Protocol 09-064]	Mulhall, John, MD
Assessing the Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy [Protocol 08-135]	Mulhall, John, MD
Clinical Significance of Germline BRCA Mutations [Protocol 96-051]	Offit, Kenneth, MD
High Intensity Focused Ultrasound for the Treatment of Low-Risk, Localized Prostate Cancer [Protocol 08-016]	Eastham, James, MD
Longitudinal Assessment of Health-Related Quality of Life in Men with Localized Prostate Cancer [Protocol 02-042]	Scardino, Peter, MD
Neoadjuvant Hormonal Therapy in Combination with Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer [Protocol 06-160]	Slovin, Susan, MD, PhD
Phase I Study of Alpharadin^TM in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases [Protocol 08-058]	Morris, Michael, MD
Phase II Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients Age 65 and Older [Protocol 08-005]	Small, Trudy, MD
Pilot Study of a Geriatric-Specific Psychoeducational Intervention for Elderly Cancer Patients [Protocol 09-116]	Roth, Andrew, MD
Radiotherapy Plus Sildenafil (Viagra) to Preserve Erectile Function Versus Radiotherapy Alone in Localized Prostate Cancer [Protocol 05-007]	Zelefsky, Michael, MD
Serum Protein Profiling to Characterize Patient Risk in Men Undergoing Radical Prostatectomy [Protocol 04-132]	Eastham, James, MD
The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men with Prostate Cancer Age 65 and Older [Protocol 06-084]	Nelson, Christian, PhD

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2010 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org